Humira Horsepower: AbbVie’s Brand Retains 98% US Market Share

Amgen’s Amjevita, the first biosimilar of Humira to launch in the US, hasn’t made headway into the US market, according to Samsung Bioepis’ quarterly market report on the US biosimilars market.